We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGO icon
126
Eldorado Gold
EGO
$8.4B
$35.7M 0.18%
992,500
-277,900
-22% -$8.32M
IDYA icon
127
IDEAYA Biosciences
IDYA
$3.48B
$35.7M 0.18%
1,031,354
+18,387
+2% +$586K
THC icon
128
Tenet Healthcare
THC
$22.6B
$35.5M 0.18%
178,601
+143,785
+413% +$29.1M
MAR icon
129
Marriott International
MAR
$101B
$35.3M 0.18%
113,756
+48,070
+73% +$13.7M
SYY icon
130
Sysco
SYY
$40.7B
$34.9M 0.17%
473,384
+223,543
+89% +$17M
WPC icon
131
W.P. Carey
WPC
$16.8B
$34.8M 0.17%
541,223
+389,918
+258% +$26M
IDXX icon
132
Idexx Laboratories
IDXX
$44.9B
$34.2M 0.17%
50,559
+27,584
+120% +$18.8M
ADBE icon
133
Adobe
ADBE
$99B
$33.2M 0.17%
94,980
+55,439
+140% +$18.9M
CGON icon
134
CG Oncology
CGON
$6.41B
$33.1M 0.17%
797,615
-240,277
-23% -$9.94M
PNC icon
135
PNC Financial Services
PNC
$100B
$32.6M 0.16%
156,350
-22,461
-13% -$4.34M
PRAX icon
136
Praxis Precision Medicines
PRAX
$8.25B
$32.6M 0.16%
110,590
+47,724
+76% +$8.89M
ULTA icon
137
Ulta Beauty
ULTA
$21.6B
$32M 0.16%
52,879
+22,030
+71% +$12.1M
GE icon
138
GE Aerospace
GE
$377B
$31.4M 0.16%
101,971
+5,150
+5% +$1.55M
CIB icon
139
Grupo Cibest SA
CIB
$21.1B
$31.2M 0.16%
490,456
+228,458
+87% +$13.7M
RYTM icon
140
Rhythm Pharmaceuticals
RYTM
$7.41B
$30.8M 0.15%
287,907
+66,044
+30% +$7.01M
CVS icon
141
CVS Health
CVS
$140B
$30.6M 0.15%
385,802
+194,844
+102% +$15.4M
EXPE icon
142
Expedia Group
EXPE
$35.5B
$30.4M 0.15%
107,444
+44,349
+70% +$11M
CBOE icon
143
Cboe Global Markets
CBOE
$31.1B
$30.3M 0.15%
120,677
+30,838
+34% +$7.67M
FUTU icon
144
Futu Holdings
FUTU
$14.3B
$30.2M 0.15%
184,046
-1,701
-0.9% -$292K
FSLR icon
145
First Solar
FSLR
$21.8B
$29.5M 0.15%
112,844
-37,535
-25% -$9.47M
RY icon
146
Royal Bank of Canada
RY
$295B
$29.5M 0.15%
172,670
+139,718
+424% +$21.5M
AMP icon
147
Ameriprise Financial
AMP
$48.3B
$28.9M 0.14%
58,845
-4,994
-8% -$2.37M
MCD icon
148
McDonald's
MCD
$194B
$28.8M 0.14%
94,209
+4,323
+5% +$1.32M
ORCL icon
149
Oracle
ORCL
$346B
$28.5M 0.14%
146,226
-34,085
-19% -$8.12M
CM icon
150
Canadian Imperial Bank of Commerce
CM
$109B
$28.1M 0.14%
309,065
-10,391
-3% -$892K

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.